Llwytho...
Clonal tracing reveals diverse patterns of response to immune checkpoint blockade
BACKGROUND: Immune checkpoint blockade (ICB) therapy has improved patient survival in a variety of cancers, but only a minority of cancer patients respond. Multiple studies have sought to identify general biomarkers of ICB response, but elucidating the molecular and cellular drivers of resistance fo...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Genome Biol |
|---|---|
| Prif Awduron: | , , , , , , , , , , , , , , , , , , , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BioMed Central
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7559192/ https://ncbi.nlm.nih.gov/pubmed/33059736 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13059-020-02166-1 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|